ARTICLE
Vol 133 No 1525: 20 November 2020

Ethnic inequities in screening for diabetes in pregnancy in New Zealand—adherence to national guidelines | OPEN ACCESS

Diabetes mellitus (DM) in pregnancy (DiP) may be due to either undiagnosed or previously unrecognised pre-gestational diabetes mellitus (type 1 or type 2 DM (T1D, T2D), or gestational diabetes mellitus (GDM).

ARTICLE
Vol 133 No 1525: 20 November 2020

COVID-19 lockdown impact on common general surgical acute presentations to a regional centre in New Zealand | OPEN ACCESS

The COVID-19 pandemic of 2020 has forever altered the landscape in global healthcare. It has highlighted how healthcare systems are impacted by a global crisis that has challenged the capabilities of medical resources and facilities worldwide.

ARTICLE
Vol 133 No 1525: 20 November 2020

Point-of-care rapid testing for hepatitis C antibodies at New Zealand needle exchanges

People who inject drugs (PWID) are a population both at substantial risk of exposure to hepatitis C (HCV) and also one facing numerous barriers to its diagnosis and treatment.

ARTICLE
Vol 133 No 1525: 20 November 2020

Feasibility and outcomes of a hepatitis C screening programme in community pharmacies

Almost 40,000 adult New Zealanders (prevalence 0.8%) have chronic hepatitis C virus (HCV) infection with an additional 1,000 new infections per annum. An estimated 20,000 remain undiagnosed, and many who have been diagnosed have been lost to follow-up and not treated.

ARTICLE
Vol 133 No 1525: 20 November 2020

Characteristics, trends and outcomes in acute coronary syndromes in the renal replacement therapy population: a 10-year retrospective analysis of the Midlands Region, New Zealand

Acute coronary syndrome (ACS) is one of the leading causes of mortality in the renal replacement therapy (RRT) population.

ARTICLE
Vol 133 No 1525: 20 November 2020

Successful use of generic direct acting antiviral medications to treat hepatitis C—a New Zealand-wide study

Hepatitis C is caused by an infection with blood-borne hepatitis C virus (HCV) that results in a chronic inflammatory process in the liver. Only a small proportion of the persons infected with HCV will develop symptomatic acute hepatitis, and while 18–34% of the patients will spontaneously clear the infection, the remainder will develop chronic disease that may lead to progressive fibrosis or cirrhosis.

ARTICLE
Vol 133 No 1525: 20 November 2020

Pregnant women’s knowledge of, and adherence to, New Zealand Food Safety in Pregnancy guidelines

Optimal nutrition is important at all stages of life but assumes even greater importance in pregnancy. During pregnancy, nutritional requirements are increased and are critical in supporting the physiological adaptations that occur during pregnancy.

ARTICLE
Vol 133 No 1525: 20 November 2020

Diabetic ketoacidosis admissions at Middlemore Hospital: observational study of cause and patient demographics

Diabetic ketoacidosis (DKA) is a serious complication of diabetes. While mortality has improved in recent years to less than 1% in most developed countries, it is associated with high healthcare utilisation and costs.

ARTICLE
Vol 133 No 1525: 20 November 2020

Point prevalence surveys of antimicrobial use in adult inpatients at Canterbury District Health Board Hospitals

Antimicrobial resistance (AMR) is a growing issue that threatens human health globally. To help combat this, both the New Zealand and Global AMR Action Plans include effective antimicrobial stewardship (AMS) as a core control measure.

ARTICLE
Vol 133 No 1525: 20 November 2020

An audit of fluid resuscitation practice in trauma patients with major haemorrhage at Christchurch Hospital

The incidence of major trauma in New Zealand is approximately 48 per 100,000 population per year, with a fatality rate of 8.4%. The majority of these deaths are due to traumatic brain or spinal cord injury, but approximately 12.6% of fatalities are due to haemorrhage, a potentially preventable cause of traumatic death.